Beyond PSA90: Deep PSA response predicts outcomes in nonmetastatic CRPC [0.03%]
PSA90以后:深度PSA反应预测非转移性CRPC患者的预后
Shuhei Hara,Keiichiro Mori,Ryotaro Yamaguchi et al.
Shuhei Hara et al.
Objectives: To evaluate whether deeper prostate-specific antigen (PSA) decline adds prognostic information beyond the conventional 90% decline benchmark (PSA90) in nonmetastatic castration-resistant prostate cancer (nmCRP...
Prostate cancer screening: Decision-making when MRI results are inconclusive for cancer (PI-RADS 3) [0.03%]
前列腺癌筛查:MRI结果无法明确判断癌症时的决策(PI-RADS 3)
Stuart G Baker
Stuart G Baker
Many patients who receive prostate magnetic resonance imaging are classified as Patient Imaging Reporting and Data Systems level 3 (PI-RADS 3), which is inconclusive for cancer. An important question is whether PI-RADS 3 patents should rece...
Evaluation of algorithms for predicting new baseline renal function after complex partial nephrectomy for multifocal renal tumors [0.03%]
评估预测多灶性肾肿瘤复杂部分肾切除术后新的基线肾功能算法的效果
Nityam Rathi,Lauren Loebach,Braden Millan et al.
Nityam Rathi et al.
Introduction: Partial nephrectomy (PN) for localized renal cancer is associated with favorable survival outcomes due to preservation of renal function. Approaches for predicting new-baseline-GFR (NBGFR) after PN have been...
Survivor-identified barriers and facilitators to acute phase recovery following radical cystectomy [0.03%]
膀胱全切术后急性期恢复的幸存者识别障碍和促进因素
Kathryn A Marchetti,Aniket Asees,Amalendu P Bokil et al.
Kathryn A Marchetti et al.
Objectives: To understand the unmet needs of bladder cancer survivors in the acute recovery after cystectomy and how remote monitoring may improve their care. These results are part of user-centered design studies on a re...
Clinical outcomes of deferred cytoreductive nephrectomy after initial systemic therapy in metastatic renal cell carcinoma: A multicenter retrospective study [0.03%]
一线系统治疗后延迟行肾细胞癌转移性根治性肾切除术的临床结局:多中心回顾性研究
Patricia Rioja,Carolina Passarella,Martín Angel et al.
Patricia Rioja et al.
Introduction: Deferred cytoreductive nephrectomy (dCN) is a selective strategy for managing metastatic renal cell carcinoma (mRCC), in the era of immune checkpoint inhibitors (ICI) and tyrosine kinase inhibitors (TKI), pa...
Hand-sewn versus stapled ileo-ileal anastomosis following radical cystectomy: A systematic review and meta-analysis [0.03%]
根治性膀胱切除术后手工缝合与金属夹吻合的回肠代膀胱效果:系统评价和meta分析
Abdelrahman Abdelshafi,Tarek Mohamed,Hamza Mohamed et al.
Abdelrahman Abdelshafi et al.
Radical cystectomy (RC) with urinary diversion is the standard treatment for muscle-invasive bladder cancer. Intestinal continuity may be restored using either hand-sewn or stapled ileo-ileal anastomosis, yet contemporary evidence comparing...
Presenting postoperative mortality as percentages and natural frequencies (1-in-N) in major urologic cancer surgeries [0.03%]
术后死亡率的表达方式(百分比与自然频率)——基于大规模泌尿系统肿瘤手术数据的分析
Izuki Ogawa,Masanao Shinohara,Naoki Fujita et al.
Izuki Ogawa et al.
Background: Perioperative mortality is usually reported as percentages, although the same risk can also be expressed as natural frequencies (e.g., 1-in-N). Presenting both formats may provide complementary ways of communi...
Insulin resistance assessed by estimated glucose disposal rate and the risk of prostate cancer [0.03%]
基于葡萄糖处置率估计值评价的胰岛素抵抗与前列腺癌发病风险的关系研究
Yuren Zhang,Jinting Xu,Yiping Zhang et al.
Yuren Zhang et al.
Introduction: Estimated glucose disposal rate (eGDR) is a validated surrogate marker of insulin sensitivity derived from clinical metabolic parameters. This study investigated the association between eGDR and prostate can...
Ankit Misra,Aditya Phadte,Vasanthapriya Subramani et al.
Ankit Misra et al.
Adrenocortical carcinoma (ACC) is a rare and aggressive malignancy arising from the adrenal cortex, characterized by local invasion and frequent distant metastases. Tumor size is a key predictor of malignancy, with lesions larger than 4 cm ...
Androgen receptor splice variant 7 (AR-V7) in castration-resistant prostate cancer: Molecular mechanisms and therapeutic strategies [0.03%]
雄激素受体剪接变体7(AR-V7)在去势抵抗性前列腺癌中的分子机制和治疗策略
Jun Li,Xiong Wang,Xiaoshuang Tang
Jun Li
Androgen receptor splice variant 7 (AR-V7) is a principal driver of resistance to androgen receptor signaling inhibitors in castration-resistant prostate cancer. By virtue of its truncated ligand-binding domain, AR-V7 functions as a constit...